Sunflower Pharmaceutical Group Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
5,025
- Stock Symbol
-
002737
- Investments
-
4
- Share Price
-
$1.75
- (As of Thursday Closing)
Sunflower Pharmaceutical Group General Information
Description
Sunflower Pharmaceutical Group Co Ltd is engaged in Research, development, production and sales of various traditional Chinese medicines and chemical drugs (including biopharmaceuticals).
Contact Information
Website
www.kuihuayaoye.comCorporate Office
- Number 18, Donghu Road, Yingbin Road Central District
- Daoli District
- Harbin, Heilongjiang 150078
- China
Corporate Office
- Number 18, Donghu Road, Yingbin Road Central District
- Daoli District
- Harbin, Heilongjiang 150078
- China
Sunflower Pharmaceutical Group Stock Performance
As of 19-Nov-2026, Sunflower Pharmaceutical Group’s stock price is $1.75. Its current market cap is $1.02B with 584M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.75 | $1.80 | $1.62 - $2.18 | $1.02B | 584M | 5.1M | -$0.03 |
Sunflower Pharmaceutical Group Financials Summary
As of 30-Sep-2026, Sunflower Pharmaceutical Group has a trailing 12-month revenue of $399M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 646,072 | 949,190 | 1,369,559 | 1,730,806 |
| Revenue | 399,348 | 322,327 | 470,638 | 805,708 |
| EBITDA | (21,726) | (14,290) | 110,350 | 212,519 |
| Net Income | (20,421) | (35,853) | 68,573 | 158,185 |
| Total Assets | 801,667 | 761,547 | 798,054 | 970,842 |
| Total Debt | 31,923 | 16,569 | 1,232 | 3,741 |
Sunflower Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sunflower Pharmaceutical Group Signals
Sunflower Pharmaceutical Group Investments & Acquisitions (4)
Sunflower Pharmaceutical Group’s most recent deal was a Merger/Acquisition with Dongxu Pharmaceutical for . The deal was made on 22-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dongxu Pharmaceutical | 22-Sep-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Hainan Huihai | 27-Sep-2023 | Merger/Acquisition | Distributors (Healthcare) | ||
| Glory (China) | 13-Apr-2022 | Corporate | Food Products | ||
| PMSTAR | 09-Nov-2021 | Corporate | Pharmaceuticals |
Sunflower Pharmaceutical Group ESG
Risk Overview
Risk Rating
Updated September, 30, 2023
34.15 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Pharmaceuticals
Industry
of 891
Rank
Percentile
Pharmaceuticals
Subindustry
of 435
Rank
Percentile
Sunflower Pharmaceutical Group Exits (1)
Sunflower Pharmaceutical Group’s most recent exit was on 27-Sep-2023 from Hainan Huihai. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Hainan Huihai | 27-Sep-2023 | Completed |
|
Sunflower Pharmaceutical Group FAQs
-
When was Sunflower Pharmaceutical Group founded?
Sunflower Pharmaceutical Group was founded in 2005.
-
Where is Sunflower Pharmaceutical Group headquartered?
Sunflower Pharmaceutical Group is headquartered in Harbin, China.
-
What is the size of Sunflower Pharmaceutical Group?
Sunflower Pharmaceutical Group has 5,025 total employees.
-
What industry is Sunflower Pharmaceutical Group in?
Sunflower Pharmaceutical Group’s primary industry is Pharmaceuticals.
-
Is Sunflower Pharmaceutical Group a private or public company?
Sunflower Pharmaceutical Group is a Public company.
-
What is Sunflower Pharmaceutical Group’s stock symbol?
The ticker symbol for Sunflower Pharmaceutical Group is 002737.
-
What is the current stock price of Sunflower Pharmaceutical Group?
As of 19-Nov-2026 the stock price of Sunflower Pharmaceutical Group is $1.75.
-
What is the current market cap of Sunflower Pharmaceutical Group?
The current market capitalization of Sunflower Pharmaceutical Group is $1.02B.
-
What is Sunflower Pharmaceutical Group’s current revenue?
The trailing twelve month revenue for Sunflower Pharmaceutical Group is $399M.
-
What is Sunflower Pharmaceutical Group’s annual earnings per share (EPS)?
Sunflower Pharmaceutical Group’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process